A study to quantify knowledge obtained during the british oncology pharmacy association (BOPA) introduction to oncology (ITO) course
Affiliation
Haematology Pharmacist, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2024
Metadata
Show full item recordAbstract
Introduction The British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) course has run for over 20 years. The ITO course is provided free of charge to BOPA PAID members, and there was an increase in cost moving to a two-day event in 2023. The BOPA Education and Training (E&T) subcommittee and BOPA Executive Committee wanted to validate that the course was meeting its objective of improving the baseline knowledge of the pharmacists and pharmacy technicians attending, and therefore justifying the increased cost to BOPA and employing organisations.Method During the ITO course in November 2023, quantitative data was collected using a questionnaire-based survey with 5-point Likert scales. This was administered to delegates at the start of each respective day to assess baseline knowledge level. Another survey was administered at the end of each respective day to re-assess knowledge level.Results There is a positive overall change for all sessions. This ranged from a + 0.92 to +1.76 improvement across the board. This was applicable regardless of profession. For all responders the greatest improvement of knowledge was seen in A. 'Extravasation of SACT' session (+1.76), 'Oncological Emergencies' (+1.51) and 'The cancer patient pathway' (+1.51) B. those with less than 6 months experience (+1.54).Conclusion This study has demonstrated that overall the ITO course improved the baseline knowledge of the delegates attending the course (+1.21). The delegates were also more confident in verifying SACT prescriptions after the course.Citation
Cracknell N, Parbutt C, Wong CY, Ganijee T. A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2024 2024 JUN 5.Journal
Journal of Oncology Pharmacy PracticeDOI
10.1177/10781552241259367PubMed ID
38835277Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1177/10781552241259367
Scopus Count
Collections
Related articles
- Initiation and preliminary evaluation of an oncology pharmacy training course for staff pharmacists.
- Authors: Saylor MS, Blanchette LM, Smith MB, Cambron K, Andricopulos K, Brown MJ
- Issue date: 2016 Aug
- British Oncology Pharmacy Association Delphi consensus guidelines: Co-infusion of trometamol-containing calcium folinate (Leucovorin) with systemic anti-cancer treatments.
- Authors: Polwart C, Root T, Tezcan S, Meehan S, Wetherill B, Waterson C, Burnett B, Chauhan R, Al-Modaris I, British Oncology Pharmacy Association Guidelines, Advocacy and Publications Committee
- Issue date: 2024 Apr 5
- Equity, diversity, and inclusion in oncology pharmacy practice: Everyone's business.
- Authors: Dettwiller P, Ghiya S, McLean J, O'Callaghan S, Sanni A, Shaunak N, So L, Williamson S, Nabhani-Gebara S
- Issue date: 2024 Jul 23
- Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients.
- Authors: Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL
- Issue date: 2013 Sep